|This Slide: #4 of 100|
Slide #4. IMS Health — Forcea
IMS Health (IMS)
IMS Health (NYSE:IMS) has acquired Forcea, a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe. The acquisition brings together IMS Health's comprehensive information and technology services with Forcea's hospital-based technology solutions to drive more effective clinical and cost decisions. Forcea solutions will leverage IMS One, the company's intelligent cloud-based platform that seamlessly provisions industry information and integrates IMS Health, client and third-party data for faster, more insightful decision making. Financial terms of the transaction were not disclosed.
IMS Health Holdings is a holding company. Co. is a global information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performances. Co. standardizes, organizes, structures and integrates data by applying its analytics and utilizing its global technology infrastructure to assist its clients run their organizations. Co. serves healthcare organizations and decision makers around the world, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Open the IMS Page at The Online Investor »
Buy (3.11 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite